Health Preservation Based on Biodiversity

Indonesia is one of the world’s megabiodiverse countries, possessing some of the greatest biological resource wealth on Earth. Its geographical position in the tropics, supported by a warm climate and high rainfall, has endowed the country with thousands of plant species with potential as medicinal plants. Many of these have been used by communities for generations as traditional remedies passed down through local wisdom. With the development of modern science, the use of medicinal plants is no longer based solely on empirical experience, but is also examined through phytochemical approaches to identify the active compounds they contain (Harborne, 1998).

Phytochemistry is the branch of science that studies the natural chemical compounds produced by plants, particularly secondary metabolites such as alkaloids, flavonoids, saponins, tannins, terpenoids, steroids, glycosides and phenolics. These compounds function as defence mechanisms for plants against attacks by microorganisms, insects and environmental stress. For humans, these secondary metabolites possess various beneficial biological activities, including antioxidant, antimicrobial, anticancer, anti-inflammatory, antidiabetic, antiviral and immunomodulatory properties (Cowan, 1999).

Indonesia’s medicinal plant potential is enormous, as the country is estimated to have more than 30,000 plant species, of which around 9,600 are known to have medicinal properties. Nevertheless, only a small proportion have been scientifically studied, whether in terms of their phytochemical content or pharmacological activity (Ministry of Health of the Republic of Indonesia, 2017). This situation shows that Indonesia still has extensive opportunities to develop research based on natural resources as raw materials for modern medicines and phytopharmaceuticals.

Various medicinal plants grown in Indonesia have been proven to contain important bioactive compounds. Turmeric, for instance, contains curcumin, which has anti-inflammatory and antioxidant activity and shows potential in inhibiting the growth of cancer cells. Javanese turmeric (temulawak) is rich in xanthorrhizol and curcuminoids, which help improve liver health and boost immunity. Ginger contains gingerol and shogaol, which are effective as antioxidants and anti-inflammatory agents and help relieve digestive disorders. Similarly, sambiloto contains andrographolide, which has antiviral and immunomodulatory activity and has been widely studied in the pharmaceutical field (WHO, 2013).

Beyond the plants already well known to the public, Indonesia also has various endemic species with the potential to yield new bioactive compounds. Research into local flora continues to expand in the search for secondary metabolites that could become candidates for new drugs. This process of exploration has become especially important given the rise in antibiotic resistance, the emergence of new diseases, and the need for safer medicines derived from nature.

In phytochemical studies, the identification of secondary metabolite content is carried out in several stages, beginning with extraction using specific solvents, qualitative phytochemical screening, separation of compounds using chromatography, and molecular structure identification using spectroscopy such as UV Vis, FTIR, NMR and GC MS. This scientific approach enables researchers to understand the relationship between the chemical structure of compounds and their biological activity, so that they can be developed into standardised herbal medicines and phytopharmaceuticals (Harborne, 1998).

The advantage of medicinal plants as a source of phytochemicals lies not only in their active compound content, but also in the synergistic effects between the various secondary metabolite components. In many cases, combinations of several active compounds can produce better therapeutic effects than the use of a single compound alone. For this reason, research into the interactions between phytochemical compounds has become one of the continuously developing fields of modern pharmacology.

The use of medicinal plants also has considerable economic value. The jamu industry, standardised herbal medicines, natural cosmetics and functional foods continue to grow alongside rising public awareness of healthy lifestyles. Indonesia has a great opportunity to become a global centre for the herbal industry, provided it is supported by scientific research, sustainable cultivation of medicinal plants, and government policies that favour the development of products based on local resources. Standardisation of quality, safety and efficacy is the primary requirement for Indonesian herbal products to compete in the international market (BPOM RI, 2022).

On the other hand, biodiversity conservation is a crucial factor in maintaining the sustainability of phytochemical resources. Excessive exploitation of medicinal plants without accompanying conservation efforts can lead to population decline and even the extinction of certain species. Therefore, conservation through cultivation, germplasm banks, conservation zones and the empowerment of local communities is an inseparable part of the strategy for developing Indonesia’s medicinal plants.

The local wisdom of indigenous communities also plays an important role in the conservation and use of medicinal plants. Knowledge of plant varieties, processing methods, dosage and indications for diseases has been passed down over hundreds of years and serves as an initial source of information in much modern phytochemical research. The ethnopharmacological approach, which combines modern science with traditional knowledge, has proven capable of accelerating the discovery of new drug candidates based on natural ingredients.

Advances in chemical analysis technology, molecular biology and bioinformatics are further strengthening phytochemical research on Indonesia’s medicinal plants. Through multidisciplinary approaches, bioactive compounds can be mapped more accurately, supporting the development of medicines that are effective, safe and meet international quality standards. With its biodiversity wealth, Indonesia has a strategic opportunity to become one of the world’s centres for phytopharmaceutical research and innovation.

Overall, the potential of Indonesia’s medicinal plants as a source of natural phytochemicals is an immensely valuable national asset. The combination of biodiversity wealth, traditional knowledge, scientific research support and sustainable management will generate various innovations in the health sector. Therefore, synergy between government, universities, industry and society must continue to be strengthened so that the potential of Indonesia’s medicinal plants becomes not only a cultural heritage, but also a foundation for the development of modern medicines, the improvement of public welfare and the preservation of Indonesia’s biodiversity.